Viewing nowRoksba Tablet 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.

MFDS item code 201603805 · Approved 2016.06.23 · Insurance code 621802890
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medication is used for hypercholesterolemia, particularly for primary hypercholesterolemia and familial hypercholesterolemia. It acts as an adjunct when dietary changes and exercise are insufficient, lowering total cholesterol and LDL cholesterol levels to delay the progression of atherosclerosis. Additionally, it is used as an adjunct to diet in children of certain age groups with high LDL cholesterol levels or risk factors for early cardiovascular disease. It is also beneficial for treating patients with dysbetalipoproteinemia and for reducing the risk of cardiovascular diseases. Specifically, it reduces the risk of stroke, myocardial infarction, and revascularization procedures in men over 50 years of age and women over 60 years of age with elevated high-sensitivity C-reactive protein levels and additional risk factors. In summary, this drug is used to improve various conditions related to hypercholesterolemia and enhance patient health by reducing the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Age 10 years to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administration of doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This drug should not be administered to certain patients. For example, individuals allergic to any component of this drug, those with severely impaired liver function, those with muscle disorders, and those with severely reduced kidney function should not take this medication. Additionally, pregnant or breastfeeding women, and women of childbearing potential who are not using appropriate contraceptive measures should consult with an expert before using this drug. This drug contains lactose, so it is not recommended for patients with lactose intolerance or related genetic disorders. It is important to regularly test liver function and muscle status when taking this drug. Particularly, individuals who consume alcohol heavily or have a history of liver disease should exercise additional caution and have their liver enzyme levels monitored regularly. If symptoms such as muscle pain or weakness occur, the healthcare provider should be notified immediately, and in severe cases, discontinuation of the medication may be necessary. This drug can interact with other medications; therefore, any current medications should be disclosed to the healthcare provider. Caution should be exercised, especially when used in combination with certain antiviral drugs, immunosuppressants, antifungals, and fibrate-class medications, as they may increase the risk of muscle damage. It is advisable not to take this drug during pregnancy, and women planning to become pregnant should use appropriate contraceptive methods. During breastfeeding, it is also advisable to avoid this medication as it may be excreted in breast milk. In case of overdose, there is no specific antidote, and treatment according to symptoms along with liver and muscle function tests is required. Patients may experience symptoms like dizziness during treatment, so they should be cautious when driving or operating machinery. Finally, this drug may present higher blood concentrations in Asians, so dosage adjustments may be necessary.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced lichenoid eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness over time.
Yellow round film-coated tablets
30 tablets/bottle, 30 tablets/box [15 tablets/Alu-Alu*2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.